As pricing pressure and commoditisation continue to weigh on traditional generics globally, pharma major Cipla is increasing its focus on differentiated respiratory products, chronic therapies, ...
Cipla Share Price Target 2026: The Indian stock market benchmark indices, Sensex and Nifty 50, remained volatile this week driven by renewed concerns over rising crude oil prices and amid stalled ...
Cipla is building a biosimilars pipeline, and aims to steadily add products over the next five years, its top executive said, as the company bets on the fast-growing market for cheaper versions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results